Scalability Metrics and Effort Requirements for a Long-Acting Injectable Antiretroviral Treatment Program
Joshua P Havens, Jennifer O’Neill, Maureen Kubat, Shawnalyn W Sunagawa, Jennifer M Davis, Nada Fadul, Joshua Lechner, Sara H Bares

TL;DR
This paper examines the effort and resources needed to scale a long-acting injectable HIV treatment program, showing it is feasible despite high operational demands.
Contribution
The study quantifies the multidisciplinary effort required to scale an injectable antiretroviral treatment program in real-world settings.
Findings
Scaling to 113 patients required 2.25 full-time equivalents over 2.5 years.
Clinical outcomes were favorable despite high operational demands.
The program demonstrated real-world feasibility and scalability.
Abstract
Implementation of a long-acting injectable antiretroviral treatment program requires substantial multidisciplinary effort, particularly for program coordination, coverage/billing, and patient support/retention. As our program scaled to 113 patients over 2.5 years, a total of 2.25 full-time equivalents were required. Despite operational demands, clinical outcomes were favorable, supporting real-world feasibility and scalability.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV/AIDS Research and Interventions · HIV/AIDS drug development and treatment · HIV-related health complications and treatments
